Common use of Debarment Limitations Clause in Contracts

Debarment Limitations. In the course of Development of the Products in the Territory, neither Party shall knowingly use any employee or consultant who is or has been debarred by the FDA or any other regulatory authority, or, to the best of such Party's knowledge, who is or has been the subject of debarment proceedings by the FDA or any such regulatory authority. Each Party shall promptly notify the other Party of and provide such other Party with a copy of any correspondence or other reports that such Party receives from any Third Party with respect to any use of a debarred employee or consultant in connection with such Party's performance of its obligations under this Agreement.

Debarment Limitations. In the course of Development of the Products Licensed Product in the TerritoryTerritory by or on behalf of a Party, neither each Party shall will not knowingly use any employee or consultant who is or has been debarred by the FDA or any other regulatory authorityRegulatory Authority, or, to the best of such Party's knowledge’s Knowledge, who is or has been the subject of debarment proceedings by the FDA or any such regulatory authorityRegulatory Authority. Each Party shall will promptly notify the other Party of of, and provide such the other Party with a copy of of, any correspondence or other reports that such Party receives from any Third Party with respect to any use of a debarred employee or consultant in connection with such Party's ’s performance of its obligations under this Agreement.

Debarment Limitations. In the course of Development of the Products in the Territory, neither Party shall knowingly use any employee or consultant who is or has been debarred by the FDA or any other regulatory authority, or, to the best of such Party's ’s knowledge, who is or has been the subject of debarment proceedings by the FDA or any such regulatory authority. Each Party shall promptly notify the other Party of and provide such other Party with a copy of any correspondence or other reports that such Party receives from any Third Party with respect to any use of a debarred employee or consultant in connection with such Party's ’s performance of its obligations under this Agreement.

Debarment Limitations. In the course of Development Commercialization of the Products in the Territory, neither Party shall knowingly use any employee or consultant who is or has been debarred by the FDA or any other regulatory authority, or, to the best of such Party's knowledge, who is or has been the subject of debarment proceedings by the FDA or any such regulatory authority. Each Party shall promptly notify the other Party of and provide such other Party with a copy of any correspondence or other reports that such Party receives from any Third Party with respect to any use of a debarred employee or consultant in connection with such Party's performance of its obligations under this Agreement.

Debarment Limitations. In the course of Development of the Products in the TerritoryTerritory by or on behalf of a Party, neither each Party shall not knowingly use any employee or consultant who is or has been debarred by the FDA or any other regulatory authorityRegulatory Authority, or, to the best of such Party's ’s knowledge, who is or has been the subject of debarment proceedings by the FDA or any such regulatory authorityRegulatory Authority. Each Such Party shall promptly notify the other Party of of, and provide such the other Party with a copy of of, any correspondence or other reports that such Party receives from any Third Party with respect to any use of a debarred employee or consultant in connection with such Party's ’s performance of its obligations under this Agreement.

Debarment Limitations. In the course of Development Commercialization of the Products in the Territory, neither Party shall knowingly use any employee or consultant who is or has been debarred by the FDA or any other regulatory authority, or, to the best of such Party's ’s knowledge, who is or has been the subject of debarment proceedings by the FDA or any such regulatory authority. Each Party shall promptly notify the other Party of and provide such other Party with a copy of any correspondence or other reports that such Party receives from any Third Party with respect to any use of a debarred employee or consultant in connection with such Party's ’s performance of its obligations under this Agreement.